Serum Institute Resumes Exports Of Covishield Vaccine

Serum Institute resumes exports of Covishield vaccine

Covishield, Covid Vaccine — Image Source: PTI FILE IMAGE The vaccine maker has actually cumulatively produced 1.25 billion dosages up until now, a company statement stated.

Emphasizes

The vaccine maker has cumulatively produced 1.25 billion dosages up until now.
SII’s supply of doses through COVAX is expected to increase substantially into Quarter 1 2022: SII
First batches of Covishield vaccines left the manufacturing facility in Pune, said the business.

Serum Institute of India on Friday stated it has resumed exports of its COVID-19 vaccine, Covishield to low- and middle-income nations with the very first batch of consignment leaving its Pune center.

The vaccine maker has cumulatively produced 1.25 billion doses up until now, a company statement said.

“The first batches of its COVISHIELD COVID-19 vaccine left the SII manufacturing center in Pune earlier today, for circulation to low- and middle-income countries through the COVAX mechanism,” it stated. “SII’s supply of doses by means of COVAX is anticipated to increase considerably into Quarter 1 2022,” it included.